-+ 0.00%
-+ 0.00%
-+ 0.00%

Xenetic grants interim CEO, CFO James Parslow 100,000 restricted shares

PUBT·04/24/2026 21:01:16
Listen to the news
Xenetic grants interim CEO, CFO James Parslow 100,000 restricted shares
  • Xenetic Biosciences granted Interim CEO and CFO James Parslow 100,000 restricted shares under its Amended and Restated Equity Incentive Plan.
  • Vesting starts with 7,000 shares on April 21, 2026.
  • Remaining 93,000 shares vest in three equal tranches on first, second, third anniversaries of April 21, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xenetic Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-003203), on April 24, 2026, and is solely responsible for the information contained therein.